Teva Pharmaceuticals
U.S. Headquarters
1090 Horsham Road
North Wales
Pennsylvania
19454
United States
Tel: 888-838-2872
Website: https://www.tevausa.com/
1781 articles about Teva Pharmaceuticals
-
Teva Pharmaceutical Industries Limited Introduces First Generic Adderall XR Capsules in the United States
4/2/2009
-
Teva Pharmaceutical Industries Limited Announces Approval of First Generic Birth Control Yaz Tablets
4/2/2009
-
Teva Pharmaceutical Industries Limited Announces Approval of Generic Yaz(R) Tablets
4/1/2009
-
Teva Pharmaceutical Industries Limited Announces Approval and Launch of Generic Topamax(R) Tablets
3/30/2009
-
Teva Pharmaceutical Industries Limited to Utilize Compugen Ltd.-Discovered Biomarkers for Pre-Clinical Detection of Drug-Induced Kidney Toxicity
3/24/2009
-
Cubist Pharmaceuticals, Inc. Suing Teva Pharmaceutical Industries Limited in Patent Dispute
3/24/2009
-
Medicis, Teva Pharmaceutical Industries Limited End Dispute Relating to Solodyn
3/19/2009
-
Teva Pharmaceutical Industries Limited Announces Approval and Launch of Generic Solodyn(R) Extended-Release Tablets
3/18/2009
-
Teva Pharmaceutical Industries Limited to Present at the Cowen and Company 29th Annual Healthcare Conference
3/16/2009
-
Sepracor, Inc. Reaches Xopenex Deal with Teva Pharmaceutical Industries Limited
3/11/2009
-
Eli Lilly and Company (JOBS) Granted Temporary Restraining Order to Halt Launch of Teva Pharmaceutical Industries Limited's Generic Raloxifene
3/10/2009
-
Teva Pharmaceutical Industries Limited to Present at the Barclays Capital Global Healthcare Conference
3/9/2009
-
ICG Commerce Selected by Teva Pharmaceutical Industries Limited to Provide Procurement Outsourcing Services
2/23/2009
-
Teva Pharmaceutical Industries Limited Invests $10.5 Million in Diabetes Drug Developer
2/18/2009
-
Teva Pharmaceutical Industries Limited to Lay Off 1,000; Croatian Staff to Get Generous Severances
2/17/2009
-
Teva Pharmaceutical Industries Limited Provides 2009 Financial Outlook
2/17/2009
-
Teva Pharmaceutical Industries Limited (JOBS) Raises 4Q Dividend
2/17/2009
-
Teva Pharmaceutical Industries Limited And Active Biotech AB Announce: Oral Laquinimod for Multiple Sclerosis Granted Fast Track Status by FDA
2/12/2009
-
Teva Pharmaceutical Industries Limited Announces Approval and Launch of Generic Imitrex(R) Tablets
2/10/2009
-
Teva Pharmaceutical Industries Limited (JOBS) COPAXONE is Approved for Treatment of Patients with a First Clinical Event Suggestive of Multiple Sclerosis
2/4/2009